Literature DB >> 19309353

G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Graeme Milligan1.   

Abstract

The concept that G protein-coupled receptors (GPCRs) can form hetero-dimers or hetero-oligomers continues to gain experimental support. However, with the exception of the GABA(B) receptor and the sweet and umami taste receptors few reported examples meet all of the criteria suggested in a recent International Union of Basic and Clinical Pharmacology sponsored review (Pin et al., 2007) that should be required to define distinct and physiologically relevant receptor species. Despite this, there are many examples in which pairs of co-expressed GPCRs reciprocally modulate their function, trafficking and/or ligand pharmacology. Such data are at least consistent with physical interactions between the receptor pairs. In recent times, it has been suggested that specific GPCR hetero-dimer or hetero-oligomer pairs may represent key molecular targets of certain clinically effective, small molecule drugs and there is growing interest in efforts to identify ligands that may modulate hetero-dimer function selectively. The current review summarizes key recent developments in these topics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309353      PMCID: PMC2795239          DOI: 10.1111/j.1476-5381.2009.00169.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  107 in total

1.  D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

Authors:  Asim J Rashid; Christopher H So; Michael M C Kong; Teresa Furtak; Mufida El-Ghundi; Regina Cheng; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

2.  Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

Authors:  Javier González-Maeso; Noelia V Weisstaub; Mingming Zhou; Pokman Chan; Lidija Ivic; Rosalind Ang; Alena Lira; Maria Bradley-Moore; Yongchao Ge; Qiang Zhou; Stuart C Sealfon; Jay A Gingrich
Journal:  Neuron       Date:  2007-02-01       Impact factor: 17.173

3.  Heterodimerization and surface localization of G protein coupled receptors.

Authors:  Kenneth P Minneman
Journal:  Biochem Pharmacol       Date:  2006-09-09       Impact factor: 5.858

4.  Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity.

Authors:  Michel Roumy; Corinne Lorenzo; Serge Mazères; Stéphanie Bouchet; Jean-Marie Zajac; Catherine Mollereau
Journal:  J Biol Chem       Date:  2007-01-15       Impact factor: 5.157

Review 5.  Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets.

Authors:  Paul A Insel; Chih-Min Tang; Ines Hahntow; Martin C Michel
Journal:  Biochim Biophys Acta       Date:  2006-10-05

6.  Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.

Authors:  James Ellis; John D Pediani; Meritxell Canals; Sandra Milasta; Graeme Milligan
Journal:  J Biol Chem       Date:  2006-10-02       Impact factor: 5.157

Review 7.  G protein-coupled receptor dimerisation: molecular basis and relevance to function.

Authors:  Graeme Milligan
Journal:  Biochim Biophys Acta       Date:  2006-09-30

Review 8.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

Authors:  Jean-Philippe Pin; Richard Neubig; Michel Bouvier; Lakshmi Devi; Marta Filizola; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Krzysztof Palczewski; Marc Parmentier; Michael Spedding
Journal:  Pharmacol Rev       Date:  2007-03       Impact factor: 25.468

9.  The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function.

Authors:  Juan F Lopez-Gimenez; Meritxell Canals; John D Pediani; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2007-01-12       Impact factor: 4.436

10.  BRET analysis of GPCR oligomerization: newer does not mean better.

Authors:  Michel Bouvier; Nikolaus Heveker; Ralf Jockers; Stefano Marullo; Graeme Milligan
Journal:  Nat Methods       Date:  2007-01       Impact factor: 28.547

View more
  138 in total

1.  Oligomeric forms of G protein-coupled receptors (GPCRs).

Authors:  Krzysztof Palczewski
Journal:  Trends Biochem Sci       Date:  2010-06-09       Impact factor: 13.807

2.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

Authors:  José L Moreno; Terrell Holloway; Laura Albizu; Stuart C Sealfon; Javier González-Maeso
Journal:  Neurosci Lett       Date:  2011-01-27       Impact factor: 3.046

3.  Signaling by sensory receptors.

Authors:  David Julius; Jeremy Nathans
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

4.  Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface.

Authors:  Chantevy Pou; Clotilde Mannoury la Cour; Leigh A Stoddart; Mark J Millan; Graeme Milligan
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

Review 5.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 6.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

Review 7.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 8.  Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye?

Authors:  Pierre Hubert; Paul Sawma; Jean-Pierre Duneau; Jonathan Khao; Jérôme Hénin; Dominique Bagnard; James Sturgis
Journal:  Cell Adh Migr       Date:  2010-04-20       Impact factor: 3.405

Review 9.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

10.  Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.

Authors:  Kaleeckal G Harikumar; Denise Wootten; Delia I Pinon; Cassandra Koole; Alicja M Ball; Sebastian G B Furness; Bim Graham; Maoqing Dong; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.